To explore the potential value of FOXS1 in the therapeutic target of CRC, we analyzed FOXS1 expression in the TCGA cohort; the results suggested that FOXS1 was significantly upregulated in CRC compared with adjacent normal tissues (P < 0.01, Fig. 1A). Here, FOXS1 is linked to colorectal carcinoma.